Last reviewed · How we verify

NCT03944278

Pilot Evaluation of Thulium Laser Alone or in Combination With Broad Band Light for Treatment of Dermatologic Conditions

Completed NA Last updated 20 October 2020
What this trial tests

NA trial testing Thulium Laser in Dermatology/Skin - Other in 15 participants. Completed in 29 September 2020.

Timeline
12 April 2019
Primary endpoint
30 August 2020
29 September 2020

Quick facts

Lead sponsorSciton
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment15
Start date12 April 2019
Primary completion30 August 2020
Estimated completion29 September 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sciton

Who can join

18 and older, any sex, with Dermatology/Skin - Other. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the Thulium laser device for skin resurfacing procedures, or as a treatment for pigmented lesions (age or sun spots) or dyschromia; or cutaneous lesions such as, but not limited to, actinic keratosis, melasma, fine rhytides; or as a method of improving skin tone and skin texture

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Thulium Laser

Trials testing the same drug.

Other recruiting trials for Dermatology/Skin - Other

Currently open trials in the same condition.

Other Sciton trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03944278.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing